DMC demonstrates full commercial scale production of L-alanine
Type of post: NEWS IN BRIEF.
DMC Biotechnologies (DMC) has successfully demonstrated the production at full commercial scale of its first product, the amino acid L-alanine.
Press release: “DMC Demonstrates Full Commercial Scale at Record Speed”, 15/03/2021.
Related post: “DMC Biotech takes important step towards commercial production of L-alanine”, 21/02/2020.
Figure 1. EW Biotech facility (taken from the press release)
The scale-up results identically tracked the performance at bench and pilot scales, further validating the predictability and scalability of DMC’s Dynamic Metabolic Control technology. Importantly, commercial performance metrics were demonstrated, meaning that no further strain improvements are required to achieve the target selling price. The scale-up process was conducted at EW Biotech’s facility (85 m3 fermentation) in Leuna (Germany).
